Table 2 Long-term outcomes in the female and male groups
From: Sex differences in utilisation of extracorporeal membrane oxygenation support and outcomes in Taiwan
Variable | Female | Male | HR or SHR | P value |
|---|---|---|---|---|
(n = 3505) | (n = 3505) | (95% CI) | ||
All-cause mortality | 2571 (73.35) | 2698 (76.98) | 0.93 (0.88–0.98) | 0.009 |
All-cause mortality after discharge | 325 (25.81) | 368 (31.32) | 0.74 (0.64—0.87) | < .001 |
CV death | 106 (8.42) | 161 (13.7) | 0.56 (0.44–0.71) | < .0001 |
Revascularization (PCI or CABG) | 8 (0.64) | 28 (2.38) | 0.26 (0.12–0.56) | 0.001 |
Acute myocardial infarction | 26 (2.07) | 36 (3.06) | 0.64 (0.39–1.07) | 0.088 |
Ischemic stroke | 21 (1.67) | 27 (2.3) | 0.67 (0.38–1.19) | 0.174 |
Hemorrhagic stroke | 12 (0.95) | 21 (1.79) | 0.51 (0.25–1.03) | 0.061 |
All-cause of readmission | 767 (60.92) | 749 (63.74) | 0.84 (0.76–0.93) | 0.001 |
Admission for heart failure | 88 (6.99) | 108 (9.19) | 0.72 (0.54–0.95) | 0.020 |
Respiratory failure | 148 (11.76) | 126 (10.72) | 1.06 (0.84–1.35) | 0.623 |
ESRD requiring permanent dialysis | 23 (2.54) | 30 (3.62) | 0.70 (0.41–1.20) | 0.192 |